The Fc protein and glyco-engineered antibodies market is projected to grow at a CAGR of over 30% during 2021-2030
With the emergence of blockbuster drugs, such as Gazyva® (for Chronic Lymphocytic Leukemia) and POTELEGIO® (for Sézary syndrome), Fc engineered antibodies have garnered significant interest in the medical community, for various clinical conditions London Roots Analysis has announced the addition of “Fc Protein and Glyco-engineered Antibodies Market2021-2030” report to its list of offerings. […]